Showing results (11-20 of 466) with videos related to
Sort By:
Pageof 47
Liver International : Official Journal of the International Association for the Study of the Liver|August 15, 2018
Controlled attenuation parameter does not predict hepatic decompensation in patients with advanced chronic liver diseaseBernhard Scheiner, Lisa Steininger, Georg Semmler, et al.Hepatology Communications|December 14, 2021
The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated CirrhosisThomas ReibergerPlos One|April 13, 2021
Influenza vaccination uptake and factors influencing vaccination decision among patients with chronic kidney or liver diseaseMichael Eder, Haris Omic, Jana Gorges, et al.Hepatology International|February 9, 2024
FXR-FGF19 signaling in the gut-liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Benedikt S Hofer, Philipp Schwabl, et al.Liver International : Official Journal of the International Association for the Study of the Liver|July 20, 2023
Hepatic recompensation according to Baveno VII criteria is linked to a significant survival benefit in decompensated alcohol-related cirrhosisBenedikt Silvester Hofer, Benedikt Simbrunner, Lukas Hartl, et al.Journal of Personalized Medicine|December 24, 2021
Cirrhosis-Associated RAS-Inflammation-Coagulation Axis Anomalies: Parallels to Severe COVID-19Lukas Hartl, Mathias Jachs, Benedikt Simbrunner, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 14, 2020
The impact of ABO blood type on the prevalence of portal vein thrombosis in patients with advanced chronic liver diseaseBernhard Scheiner, Patrick G Northup, Anselm B Gruber, et al.Clinical and Molecular Hepatology|December 14, 2022
Eating, diet, and nutrition for the treatment of non-alcoholic fatty liver diseaseGeorg Semmler, Christian Datz, Michael TraunerJournal of Gastroenterology and Hepatology|May 8, 2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertensionGeorg Semmler, Benedikt Simbrunner, Bernhard Scheiner, et al.Digestive Diseases and Sciences|June 19, 2019
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal HypertensionGeorg Semmler, Judith Stift, Bernhard Scheiner, et al.Pageof 47